CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. - Concepedia

Concepedia

Publication | Closed Access

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

448

Citations

32

References

1992

Year

N Masuda, M. Fukuoka, Y Kusunoki, Kunihiko Matsui, Nobuhide Takifuji, S. Kudoh, S Negoro, Masayuki Nishioka, Kazuhiko Nakagawa, Mitsutaka Takada

Journal of Clinical Oncology

Abstract

CPT-11 is an active agent against refractory or relapsed SCLC and deserves to be studied more closely as both a single agent and in combination with other drugs to treat patients with SCLC.

References

	Year	Citations

Page 1